This 5 minute video discusses the paper, and in concluding remarks, Dr. DeMaria states that the incremental risk related to clopidogrel use prior to CABG surgery is related to timing, and continues to recommend that the 5 day waiting period is necessary.

View the video

Download the paper (pdf)

About EPI-Q, Inc.
EPI-Q, Inc. (www.epi-q.com) provides life sciences companies and healthcare providers and payer organizations with evidence-based solutions that elucidate the value of medical technology and improve health outcomes and cost-effectiveness. EPI-Q's professionals have extensive expertise in medicine, pharmacy, epidemiology, biostatistics, economics, business and healthcare administration. In addition, many of these experts maintain academic affiliations, publish and present frequently on issues pertaining to quality improvement and outcomes management.

Contacts:
Mark Jewell, PhD
President
EPI-Q, Inc.
Tel: 630.570.5505
Fax: 630.570.5506
Email: mark.jewell@epi-q.com

Andrew M. Baker
Vice President—Business Development
EPI-Q, Inc.
Tel: 914.358.3264
Fax: 914.358.3265
Email: drew.baker@epi-q.com